Strategic Communications
What we do
We work at the intersection of the strategy, language and execution layers of science communications — from foundational story architecture to fit-for-purpose messaging to publication-ready content, and from investor narratives to editorial strategy for sustained visibility. Our work ranges from deeply technical to broadly accessible, but our approach stays the same: understand your audience, clarify the decision they need to make, and craft the language that guides them there.
Knowledge translation is core to this practice. It is the deliberate process of ensuring that scientific evidence and innovation reach the audiences — investors, policymakers, clinicians, funders, communities — who can act on it. It is the difference between a finding that sits in a journal and one that changes a funding decision, a clinical protocol, or a public health response.
Services
Storytelling & knowledge translation frameworks
The foundation that defines how your organization, platform, or program speaks — across audiences, channels, and contexts. It includes core narrative, value proposition, audience-specific messaging, and key claims mapped to evidence, and is built to serve fundraising, regulatory, program communications, and public audiences simultaneously.
Investor narrative development
The written narrative that supports a raise — pitch narrative, one-pagers, executive summaries, and the story that makes your science digestible and your opportunity compelling. We have deep familiarity with what biotech and deep tech investors need to see, and how they need to see it.
Global health & development communications
We partner with mission-driven organizations to make complex, high-stakes work approachable — to the public, to partners, and to people inside the institution. Bold global health ambitions require stories that move people, not just inform them. This is a dedicated practice area at Cognition, led by communications professionals with deep roots in global health, journalism, and policy.
Science communications strategy
An editorial and communications plan for organizations building a sustained presence in the scientific or public conversation — defining what to say, when, in which formats, and for whom. Especially relevant for synbio, One Health, and AI-bio companies working to establish new categories and build public understanding of emerging science.
Regulatory & clinical communications
Structured writing for regulatory submissions, clinical trial communications, and patient-facing materials — precise, compliant, and calibrated to the expectations of the audience and the regulatory environment.
Executive thought leadership
Content strategy and development for founders, executives, and scientific leaders — positioning them as credible, substantive voices in their field. Includes content planning, ghostwriting, and editorial strategy.
Who this is for
Biotech and pharma companies preparing for a fundraise, product launch, or regulatory submission. Global health organizations and foundations communicating program outcomes to donors, governments, and communities. Synbio, One Health, and AI-bio companies building narratives for emerging categories that don’t yet have established vocabulary. Any organization with a scientific story to tell and audiences that need to act on it.